News
New test for STI in a bid to stop superbug
An Australian-developed test for gonorrhoea has been created to help stop the spread of antibiotic resistance and to tailor treatment …
Continue ReadingTreat gonorrhoea with Resistance Guided Therapy
Updated treatment guidelines and the availability of the ResistancePlus® GC test for Neisseria gonorrhoeae from SpeeDx, are making it possible …
Continue ReadingSpeeDx Increase European Distribution Network
SpeeDx announced signing two new distribution partners, creating comprehensive access for customers to market-leading SpeeDx ResistancePlus® and PlexPCR® tests across …
Continue ReadingGonorrhoea guidelines call for ciprofloxacin susceptibility testing
The British Association for Sexual Health and HIV (BASHH) have published new guidelines for the management of gonorrhoea infections with …
Continue ReadingTwo new cases of resistant gonorrhoea diagnosed in the UK
Public Health England (PHE) is investigating two cases of extensively drug resistant (XDR) gonorrhoea recently diagnosed in the U.K. XDR …
Continue ReadingResistancePlus® GC receives CE-IVD mark
SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually …
Continue ReadingJohns Hopkins raising awareness of Mycoplasma genitalium resistance test for reproductive health
Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness …
Continue ReadingSpeeDx broaden European Distribution Network
SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and …
Continue ReadingDraft BASHH gonorrhoea guidelines recommend ciprofloxacin susceptibility testing
Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. …
Continue ReadingSpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG
SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus MG. “This test is an …
Continue Reading